Cornercap Investment Counsel Inc Horizon Therapeutics Public LTD CO Transaction History

Cornercap Investment Counsel Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $201,447 - $289,486	3,419 Added 15.35%	25,687 $1.59 Million
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $1.77 Million - $2.59 Million	22,268 New	22,268 $1.78 Million
Q2 2021 Aug 16, 2021	SELL	$86.24 - $95.92 $1.21 Million - $1.35 Million	-14,053 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$71.83 - $95.48 $1.14 Million - $1.51 Million	-15,858 Reduced 53.02%	14,053 $1.29 Million
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $1.08 Million - $1.36 Million	16,087 Added 116.37%	29,911 $1.08 Million

Q3 2020 Nov 13, 2020	SELL	$55.23 - $79.93 $206,946 - $299,497	-3,747 Reduced 21.32%	13,824 $1.07 Million
Q2 2020 Aug 13, 2020	SELL	$30.2 - $56.98 $350,954 - $662,164	-11,621 Reduced 39.81%	17,571 $977,000
Q1 2020 May 11, 2020	SELL	$24.87 - $38.56 $115,148 - $178,532	-4,630 Reduced 13.69%	29,192 $865,000
Q4 2019 Feb 14, 2020	SELL	$25.43 - $36.67 $103,067 - $148,623	-4,053 Reduced 10.7%	33,822 $1.22 Million
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $863,928 - $1.08 Million	37,875 New	37,875 $911,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Cornercap Investment Counsel Inc with notifications on news.